ArticleInternational journal of general medicine2022

MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.

Meng Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.